Sare Hosseini

482 total citations
45 papers, 343 citations indexed

About

Sare Hosseini is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Sare Hosseini has authored 45 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 14 papers in Surgery. Recurrent topics in Sare Hosseini's work include Silymarin and Mushroom Poisoning (7 papers), Colorectal Cancer Surgical Treatments (6 papers) and Advanced Radiotherapy Techniques (6 papers). Sare Hosseini is often cited by papers focused on Silymarin and Mushroom Poisoning (7 papers), Colorectal Cancer Surgical Treatments (6 papers) and Advanced Radiotherapy Techniques (6 papers). Sare Hosseini collaborates with scholars based in Iran, United States and United Kingdom. Sare Hosseini's co-authors include Sepideh Elyasi, Gholamreza Karimi, Seyed Amir Aledavood, Hedyieh Karbasforooshan, Jamshidkhan Chamani, Hamid Reza Rahimi, Ali Kermani, Μohammad Mohammadianpanah, Roham Salek and Alimohammad Bananzadeh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Oncology and Journal of Cellular Physiology.

In The Last Decade

Sare Hosseini

40 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sare Hosseini Iran 10 118 97 96 57 46 45 343
Rakesh Dhankhar India 9 63 0.5× 125 1.3× 74 0.8× 57 1.0× 15 0.3× 36 363
Émilie Gadéa France 10 76 0.6× 167 1.7× 182 1.9× 65 1.1× 33 0.7× 20 466
Maddalena Leongito Italy 15 107 0.9× 106 1.1× 132 1.4× 62 1.1× 55 1.2× 37 675
Júlia C.F. Quintanilha United States 13 103 0.9× 159 1.6× 172 1.8× 32 0.6× 26 0.6× 63 520
Hyun Hwan Sung South Korea 11 152 1.3× 68 0.7× 27 0.3× 45 0.8× 32 0.7× 34 320
Xiaokun Lin China 12 53 0.4× 119 1.2× 29 0.3× 29 0.5× 49 1.1× 34 434
Péter Barta Hungary 7 58 0.5× 97 1.0× 35 0.4× 45 0.8× 31 0.7× 9 519
Jiangfeng Wang China 13 140 1.2× 121 1.2× 212 2.2× 8 0.1× 14 0.3× 26 458
J. Zhang United States 12 365 3.1× 108 1.1× 311 3.2× 19 0.3× 33 0.7× 18 776
Guoqing Zhang China 12 68 0.6× 90 0.9× 65 0.7× 19 0.3× 58 1.3× 38 388

Countries citing papers authored by Sare Hosseini

Since Specialization
Citations

This map shows the geographic impact of Sare Hosseini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sare Hosseini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sare Hosseini more than expected).

Fields of papers citing papers by Sare Hosseini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sare Hosseini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sare Hosseini. The network helps show where Sare Hosseini may publish in the future.

Co-authorship network of co-authors of Sare Hosseini

This figure shows the co-authorship network connecting the top 25 collaborators of Sare Hosseini. A scholar is included among the top collaborators of Sare Hosseini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sare Hosseini. Sare Hosseini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hosseini, Sare, Nahid Askari, & Mohammad Mehdi Yaghoobi. (2025). Combined anti-tumor effects of metformin and azacitidine in breast cancer cells. BMC Cancer. 25(1). 1487–1487. 1 indexed citations
2.
Shandiz, Fatemeh Homaei, et al.. (2025). Capecitabine-Enhanced Brachytherapy in Locally Advanced Cervical Cancer: A Phase II Non-Randomized Trial on Safety and Efficacy. Cancer Investigation. 43(4). 244–256. 1 indexed citations
3.
Mosleh‐Shirazi, Mohammad Amin, et al.. (2024). Evaluating the dosimetric impact of deep‐learning‐based auto‐segmentation in prostate cancer radiotherapy: Insights into real‐world clinical implementation and inter‐observer variability. Journal of Applied Clinical Medical Physics. 26(3). e14569–e14569. 4 indexed citations
4.
Karimi, Gholamreza, et al.. (2024). Evaluation of oral silymarin formulation efficacy in prevention of doxorubicin induced hepatotoxicity in patients with non-metastatic breast cancer. Journal of Oncology Pharmacy Practice. 31(6). 965–976. 1 indexed citations
5.
Ghasemi, Hassan, et al.. (2024). Non-coding RNA biosensors for early detection of brain cancer. Clinica Chimica Acta. 566. 120041–120041. 7 indexed citations
6.
Gharib, Masoumeh, et al.. (2023). Pathology Reports: Discrepancy Patterns of Second Opinions in a Referral Cancer Center. Cancer Investigation. 41(3). 284–291. 1 indexed citations
7.
Hosseini, Sare, Mohammad Sadegh Soltani‐Zangbar, Majid Zamani, et al.. (2023). Comparative evaluation of autologous platelet-rich plasma and platelet lysate in patients with knee osteoarthritis. Growth Factors. 41(3). 165–177. 7 indexed citations
8.
Elyasi, Sepideh, et al.. (2022). Topical henna and curcumin (Alpha®) ointment efficacy for prevention of capecitabine induced hand-foot syndrome: A randomized, triple-blinded, placebo-controlled clinical. DARU Journal of Pharmaceutical Sciences. 30(1). 117–125. 6 indexed citations
9.
Jarahi, Lida, et al.. (2022). Assessment of I-CAM1, V-CAM1, and E-selectin Serum Levels in Patients with Breast and Pelvic Cancer: A Case Control Study. International Journal of Cancer Management. 15(11).
10.
Hosseini, Sare, et al.. (2021). The Prognostic Role of Body Mass Index in Survival of Non-metastatic Postoperative Patients with Colorectal Cancer. International Journal of Cancer Management. 14(3). 3 indexed citations
11.
Hosseini, Sare, Mehdi Momennezhad, & S. Naseri. (2020). Dosimetric comparison of conventional and field-in-field techniques in early-stage breast cancer radiotherapy. Iranian Journal of radiation research. 18(3). 487–494.
12.
Kermani, Ali, Sare Hosseini, Mona Joudi Mashhad, et al.. (2018). A randomized clinical trial on the antitumoral effects of low molecular weight heparin in the treatment of esophageal cancer. Journal of Cellular Physiology. 234(4). 4191–4199. 24 indexed citations
14.
Hosseini, Sare, et al.. (2017). Prognostic significance of mucinous histologic subtype on oncologic outcomes in patients with colorectal cancer. Annals of Oncology. 28. iii102–iii102. 1 indexed citations
16.
17.
Kermani, Ali, Sare Hosseini, Roham Salek, & Leila Pourali. (2015). Improving Knowledge and Attitude of Nurses Working In Chemotherapy Wards through a Short Educational Course: A Successful Experience in Mashhad. 5(4). 10–13. 4 indexed citations
18.
Hosseini, Sare, et al.. (2015). Small Cell Carcinoma of the Esophagus: Clinicopathological Features and Outcome of 22 Cases. Iranian Red Crescent Medical Journal. 17(11). e20353–e20353. 6 indexed citations
19.
Hosseini, Sare, et al.. (2014). The effect of relaxation training on breastfeeding self-efficacy of mothers with preterm infants: A randomized clinical trial. SHILAP Revista de lepidopterología. 13 indexed citations
20.
Anvari, Kazem, et al.. (2013). Evaluation of Educational Requirements among Iranian Cancer Patients Undergoing Radiotherapy. 1(2).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026